Abstract
A series of chalcone derivatives (1a–2i) were designed based on isoliquiritigenin (the most active natural chalcone non-competitive neuraminidase (NA) inhibitor). Molecular modeling studies revealed that isoliquiritigenin and its designed analogs occupied 430-loop cavity of NA and interacted favorably with catalytic site residues. The favorable derivatives were synthesized and evaluated for cytotoxicity and for inhibition of cytopathic effect by H1N1 virus. The inhibitory effect was further quantified by heamagglutinition (HA) assay, H1N1-NA inhibition, and kinetics of inhibition. The HA assay showed compound 1e has the lowest EC50 of 1.71 nM. In contrast, the H1N1-NA inhibition assay showed compound 1f has the best activity with the IC50 of 3.58 μM. Enzyme kinetic study suggested that the inhibition mechanism of compounds 1f and 2f was non-competitive.
Similar content being viewed by others
References
An J, Lee DC, Law AH, Yang CL, Poon LL, Lau AS, Jones SJ (2009) A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. J Med Chem 52:2667–2672
Chintakrindi A, D’Souza C, Kanyalkar M (2012) Rational development of neuraminidase inhibitor as novel anti-flu drug. Mini Rev Med Chem 12:1273–1281
Colman PM, Tulip WR, Varghese JN, Tulloch PA, Baker AT, Laver WG, Air GM, Webster RG (1989) Three-dimensional structures of influenza virus neuraminidase-antibody complexes. Philos Trans R Soc Lond B Biol Sci 323:511–518
Dao TT, Nguyen PH, Lee HS, Kim E, Park J, Lim SI, Oh WK (2011) Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata. Bioorg Med Chem Lett 21:294–298
Dao TT, Tung BT, Nguyen PH, Thuong PT, Yoo SS, Kim EH, Kim SK, Oh WK (2010) C-methylated flavonoids from Cleistocalyx operculatus and their inhibitory effects on novel influenza A (H1N1) neuraminidase. J Nat Prod 73:1636–1642
Diller DJ, Merz Jr. KM (2001) High throughput docking for library design and library prioritization. Proteins 43:113–124
Gong J, Xu W, Zhang J (2007) Structure and functions of influenza virus neuraminidase. Curr Med Chem 14:113–122
Hosseini S, Amini E, Kheiri M, Mehrbod P, Shahidi M, Zabihi E (2012) Anti-influenza activity of a novel polyoxometalate derivative (POM-4960). Int J Mol Cell Med 1:21–29
Jeong HJ, Ryu YB, Park SJ, Kim JH, Kwon HJ, Park KH, Rho MC, Lee WS (2009) Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg Med Chem 17:6816–6823
Kim CU, Chen X, Mendel DB (1999) Neuraminidase inhibitors as anti-influenza virus agents. Antivir Chem Chemother 10:141–154
Kobasa D, Rodgers ME, Wells K, Kawaoka Y (1997) Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks. J Virol 71:6706–6713
Lentz MR, Webster RG, Air GM (1987) Site-directed mutation of the active site of influenza neuraminidase and implications for the catalytic mechanism. Biochemistry 26:5351–5358
Magano J (2009) Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza. Chem Rev 109:4398–4438
Momany FA, Rone R (1992) Validation of the general purpose QUANTA®3.2/CHARMm® force field. J Comput Chem 13:888–900
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Nguyen TNA, Dao TT, Tung BT, Choi H, Kim E, Park J, Lim S-IL, Oh WK (2011) Influenza A (H1N1) neuraminidase inhibitors from Vitis amurensis. Food Chem 124:437–443
Oxford JS, Novelli P, Sefton A, Lambkin R (2002) New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors. Antivir Chem Chemother 13:205–217
Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45–49
Ryu YB, Kim JH, Park SJ, Chang JS, Rho MC, Bae KH, Park KH, Lee WS (2010) Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg Med Chem Lett 20:971–974
Serkedjieva J, Velcheva M (2003) In vitro anti-influenza virus activity of the pavine alkaloid (–)-thalimonine isolated from Thalictrum simplex L. Antivir Chem Chemother 14:75–80
Singh P, Anand A, Kumar V (2014) Recent developments in biological activities of chalcones: a mini review. Eur J Med Chem 85:758–777
Syam S, Abdelwahab SI, Al-Mamary MA, Mohan S (2012) Synthesis of chalcones with anticancer activities. Molecules 17:6179–6195
World Health Organisation (2015a) Avian influenza in humans. http://www.who.int/influenza/human_animal_interface/avian_influenza/en/. Accessed 31 Oct 2015
World Health Organisation (2014) Influenza (Seasonal)—Fact sheet N°211. http://www.who.int/mediacentre/factsheets/fs211/en/. Accessed 31 Oct 2015
World Health Organisation (2015b) Swine influenza in humans. http://www.who.int/influenza/human_animal_interface/swine_influenza/en/. Accessed 31 Oct 2015
Williamson JC, Pegram PS (2000) Respiratory distress associated with Zanamivir. N Engl J Med 342:661–662
Xu X, Zhu X, Dwek RA, Stevens J, Wilson IA (2008) Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol 82:10493–10501
Zerong W (2010) Claisen-Schmidt condensation. In: Zerong W (ed) Comprehensive organic name reactions and reagents. Wiley, Hoboken, NJ, pp 660–664
Acknowledgements
M.A.K. thanks Indian Council of Medical Research (ICMR), New Delhi for funding computational facilities at Prin. K. M. Kundnani College of Pharmacy through Adhoc research scheme (58/27/2007-BMS). A.S.C. also thanks ICMR, New Delhi for Senior Research Fellowship (58/27/2007-BMS). D.J.G., S.T.K., and A.S.C. acknowledge National Center for Disease Control (NCDC), New Delhi, for providing Madin-Darby canine kidney (MDCK) cell line and thank National Institute of Virology for providing seasonal Influenza A (H1N1) Pune Isolate for neuraminidase inhibition assay.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Rights and permissions
About this article
Cite this article
Chintakrindi, A.S., Gohil, D.J., Kothari, S.T. et al. Design, synthesis and evaluation of chalcones as H1N1 Neuraminidase inhibitors. Med Chem Res 27, 1013–1025 (2018). https://doi.org/10.1007/s00044-017-2124-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-017-2124-2